Results 111 to 120 of about 274,323 (195)

Waist Circumference predicting Cardiovascular Disease in Korean Men and Women

, 2010
Objective: Obesity and cardiovascular disease (CVD) are closely related and have become increasingly prevalent in Korea. Asians are more prone to obesity-related co-morbidities than Caucasians, even at lower body mass index (BMI) and/or smaller waist ...
Sun Ha Jee, Sat Byul Park
core  

Endogenous adenine is a potential driver of the cardiovascular-kidney-metabolic syndrome

Abstract Mechanisms underlying the cardiovascular-kidney-metabolic (CKM) syndrome are unknown, although key small molecule metabolites may be involved. Bulk and spatial metabolomics identified adenine to be upregulated and specifically enriched in coronary blood vessels in hearts from patients with diabetes and left ventricular ...
Ian Tamayo, Hak Joo Lee, M. Imran Aslam, Jian-Jun Liu, Nagarjunachary Ragi, Varsha Karanam, Soumya Maity, Afaf Saliba, Esmeralda Treviño, Huili Zheng, Su Chi Lim, Jan D. Lanzer, Petter Bjornstad, Katherine Tuttle, Kenneth C. Bedi, Kenneth B. Margulies, Vasan Ramachandran, Ahmed Abdel-Latif, Julio Saez-Rodriguez, Ravi Iyengar, Jean C. Bopassa, Kumar Sharma   +21 more
openaire   +2 more sources

Antioxidant Effects of SGLT2 Inhibitors on Cardiovascular–Kidney–Metabolic (CKM) Syndrome

Antioxidants
The cardiovascular–kidney–metabolic (CKM) syndrome was recently conceptualized to provide a holistic framework for diagnosing and treating the full spectrum of key age-associated interrelated conditions: overweight/obesity, type 2 diabetes mellitus ...
Juan Guerrero-Mauvecin, Natalia Villar-Gómez, Lucia Miño-Izquierdo, Adrián Povo-Retana, Adrian M. Ramos, Gema Ruiz-Hurtado, Maria D. Sanchez-Niño, Alberto Ortiz, Ana B. Sanz   +8 more
doaj   +1 more source

The impact of type 2 diabetes and Microalbuminuria on future cardiovascular events in patients with clinically manifest vascular disease from the Second Manifestations of ARTerial Disease (SMART) study

, 2008
Aims Type 2 diabetes mellitus and microalbuminuria are important risk factors for cardiovascular disease (CVD). Whether these two complications are important and independent risk factors for future CVD events in a high-risk population with clinically ...
Graaf, Y., van der, Algra, A., van der Graaf, Y., Soedamah-Muthu, S.S., Visseren, F.L.J.   +4 more
core   +1 more source

Impact of Cardiovascular–Kidney–Metabolic Syndrome Staging on Myocardial Infarction Outcomes: A Retrospective Analysis of 2.7 Million Patients

Background: Cardiovascular–kidney–metabolic (CKM) syndrome, recently defined by the American Heart Association, encompasses the interplay between obesity, diabetes, chronic kidney disease, and cardiovascular disease.
Abu-Fanne, Rami, Shabtai, Ronny, Roguin, Ariel, Folman, Adam, Gatuz, Marlon Villaga, Barel, Maguli S., Abramov, Dmitry, Kobo, Ofer, Mamas, Mamas A.   +8 more
core   +1 more source

The Prevalence of Metabolic Syndrome in Patients on Hemodialysis and Peritoneal Dialysis: A Comparative Study

مجله دانشکده پزشکی اصفهان, 2012
Background: One of the major causes of mortality in patients with kidney failure requiring dialysis is cardiovascular diseases. Metabolic syndrome refers to a collection of metabolic disorders that causes systemic inflammation and therefore plays an ...
Mojgan Mortazavi, Shiva Seirafian, Afsoon Emami Naini, Neda Zamani, Nafiseh Moien   +4 more
doaj  

A logistic regression model for microalbuminuria prediction in overweight male population

, 2010
Background: Obesity promotes progression to microalbuminuria and increases the risk of chronic kidney disease. Current protocols of screening microalbuminuria are not recommended for the overweight or obese. Design and Methods: A cross-
Chen Yu, ZhenYun Ni, DaWei Cui, WeiYi Xu, XueFen Li, BaoDe Chen   +5 more
core  

Neighborhood Walkability and Cardio-Kidney-Metabolic Syndrome: A Narrative Review

Cardio-Kidney-Metabolic (CKM) Syndrome is a complex systemic disorder characterized by interactions between metabolic risk factors such as obesity, Type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD), and cardiovascular disease (CVD).
Pedro Rafael Vieira de Oliveira Salerno, Vaibhav Shah, Colin Carpenter, Alena Gonzalez, Mohamed Bassiony, Avery Hum, Zhuo Chen, Ariela Baur, Weichuan Dong, Sadeer Al-Kindi   +9 more
core   +1 more source

Olive oil in metabolic syndrome

, 2016
The prevalence of metabolic syndrome (MS) is rising in developing countries and developed countries at such high rates that it is now considered a worldwide public health problem of pandemic proportions.
Perona, Javier S.
core  

Hyperaldosteronism in the Pathophysiology and Management of Cardiovascular-Kidney-Metabolic Syndrome. [PDF]

Diabetes Obes Metab
Zeitler E, Klein KR, Lingvay I, Pick A, Billings LK.   +4 more
europepmc   +1 more source